Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 5419, 2018 04 03.
Article in English | MEDLINE | ID: mdl-29615659

ABSTRACT

The important component of obesity pathogenesis is inflammatory activation of innate immune cells within adipose tissue and in other body locations. Both the course of obesity and innate immune reactivity are characterized by sex-associated differences. The aim of the work was a comparative investigation of metabolic profiles of phagocytes from different locations in male and female rats with MSG-induced obesity. The administration of monosodium glutamate (MSG) caused obesity, with sex-associated differences, that was more severe in male rats. Obesity was associated with pro-inflammatory activation of CD14+ phagocytes from adipose tissue in female, but not in male rats, which was demonstrated by decreased phagocytosis activity along with increased ROS generation. Phagocytes from the peritoneal cavity and peripheral blood of obese female rats exhibited neutral metabolic profile, whereas those cells from obese male rats displayed a pro-inflammatory metabolic profile. Thus, the manifestation of obesity-induced inflammation was characterized by different patterns of metabolic profile of phagocytes in male and female rats. Identified immune cell characteristics expand our knowledge of obesity immunobiology and may help to develop more effective preventive and therapeutic interventions for obese patients of different sexes.


Subject(s)
Metabolomics , Obesity/chemically induced , Obesity/metabolism , Phagocytes/drug effects , Phagocytes/metabolism , Sex Characteristics , Sodium Glutamate/adverse effects , Adipose Tissue, White/drug effects , Adipose Tissue, White/metabolism , Animals , Female , Male , Obesity/pathology , Obesity/physiopathology , Rats
2.
Curr Pharm Biotechnol ; 16(1): 49-59, 2015.
Article in English | MEDLINE | ID: mdl-25395210

ABSTRACT

OBJECTIVE: The aim of the work was to evaluate the effect of moderate physical exercise on the response of circulating phagocytes to the antineoplastic drug NSC 631570. METHODS: Eight healthy adult men aged 23 ± 2 years were recruited to participate in the study; NSC 631570 was administered i.v. in a single therapeutic dose; blood samples were collected before and after the drug administration; the moderate physical exercise programme included 50 slow squats; total leukocyte, neutrophil and lymphocyte counts were determined using the haematological analyser; intracellular ROS generation and phagocytic activity of circulating monocytes and granulocytes were analysed by flow cytometry; PPAR-γ protein expression was evaluated by Western blot. RESULTS: introduction of NSC 631570 in an inpatient setting was associated with a decrease in phagocyte endocytic activity along with an increase in ROS generation. Drug injection in an outpatient setting was accompanied by a significant increase in monocyte and granulocyte phagocytosis along with a decrease in the daily mean of ROS generation as well as by a decrease in monocyte reactivity reserve after stimulation in vitro. PPAR-γ expression in circulating monocytes was significantly decreased after the drug administration in an inpatient setting and was slightly increased in active participants after the drug injection. CONCLUSION: NSC 631570 causes M1 (N1) shift of phagocytes after in vivo introduction. Moderate physical exercise exerts a negative effect on the immunomodulatory action of NSC 631570 by abrogating M1 (N1) shift of circulating phagocytes. One of the reasons for such an effect could be an increase in PPAR-γ expression by phagocytes.


Subject(s)
Adjuvants, Immunologic/pharmacology , Antineoplastic Agents/pharmacology , Berberine Alkaloids/pharmacology , Exercise , Phagocytosis/drug effects , Phenanthridines/pharmacology , Adult , Granulocytes/drug effects , Granulocytes/physiology , Humans , Leukocyte Count , Male , Monocytes/drug effects , Monocytes/physiology , Reactive Oxygen Species/blood , Staphylococcus aureus , Young Adult
3.
Cytokine ; 57(1): 81-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22137122

ABSTRACT

BACKGROUND: It is well-known that tumor exerts nonmetastatic systemic effect on organism caused the development of paraneoplastic syndrome (PNS). Recent findings point to relationships between development of PNS and tumor-derived vascular endothelial growth factor (VEGF). AIM: Comparative study of PNS manifestations in mice with transplanted two variants of Lewis lung carcinoma with different angiogenic potential. METHODS: Plasma VEGF level was determined by immunoenzyme method, hematological indices were estimated with the use of hematological analyzer, the weight and cellularity of spleen and thymus were registered and histological analysis of tissue section of these organs was performed. RESULTS: Manifestations of anemia, extramedullary hemopoiesis and tumor-associated inflammatory disease was observed in animals with high angiogenic LLC/R9 variant and was not registered in low angiogenic LLC. The emergence of PNS symptoms correlated with elevated level of circulating VEGF at the early stages of LLC/R9 growth. CONCLUSION: Manifestation of the paraneoplastic hematological syndrome most likely is conditioned on the ability of cancer cell to secrete VEGF in a high rate.


Subject(s)
Carcinoma, Lewis Lung/blood supply , Carcinoma, Lewis Lung/complications , Neovascularization, Pathologic/complications , Paraneoplastic Syndromes/complications , Paraneoplastic Syndromes/pathology , Vascular Endothelial Growth Factor A/metabolism , Anemia/blood , Anemia/complications , Animals , Carcinoma, Lewis Lung/blood , Carcinoma, Lewis Lung/pathology , Cell Proliferation , Hematopoiesis, Extramedullary , Kinetics , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Neoplasm Transplantation , Neovascularization, Pathologic/blood , Organ Size , Paraneoplastic Syndromes/blood , Spleen/metabolism , Spleen/pathology , Thymus Gland/pathology , Vascular Endothelial Growth Factor A/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...